Last reviewed · How we verify
NCT06492551: TRAK-COVID
Post-COVID-19 Patients With Trak Tool
NA trial testing Trak exercise prescription protocol in Post COVID-19 Condition in 80 participants. Completed in 5 October 2022.
23 September 2022
Quick facts
| Lead sponsor | Trak Health Solutions S.L. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 16 March 2022 |
| Primary completion | 23 September 2022 |
| Estimated completion | 5 October 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Trak exercise prescription protocol
- Conventional rehabilitation plan in the gym
Conditions studied
- Post COVID-19 Condition — all drugs for Post COVID-19 Condition →
Sponsor
Trak Health Solutions S.L. — full company profile →
Who can join
18 and older, any sex, with Post COVID-19 Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical trial aims to analyse the effectiveness of a physiotherapeutic exercise program delivered through the telerehabilitation tool (Trak) compared to a booklet-based rehabilitation format in post-COVID-19 patients. This research seeks to provide insights into the acceptance of the TRAK tool in this specific population, contributing to the advancement of understanding in this field. Participants will be assigned to either the control group, which will receive conventional rehabilitation, or the experimental group, which will undergo telerehabilitation. Both groups will undergo a 6-week physical intervention, with pre- and post-intervention evaluations. Researchers will compare the control and experimental groups to determine if there are significant differences in the health conditions of each group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06492551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post COVID-19 Condition
Currently open trials in the same condition.
- NCT07110714 — Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients · NA · recruiting
- NCT06156176 — Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial · NA · recruiting
- NCT06766825 — Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) · Phase 2 · recruiting
- NCT05946512 — MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention · NA · recruiting
- NCT05890534 — Pycnogenol® in Post-COVID-19 Condition · Phase 3 · active not recruiting
Other Trak Health Solutions S.L. trials
Trials by the same sponsor.
- NCT06720779 — Virtual Rehabilitation Platform for Patients With Knee Prothesis · NA · recruiting
- NCT06796309 — Assessment of Rural Health Care: Implementing TRAK Digital Tool for Quality and Accessible Services · NA · recruiting
- NCT06699875 — Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal · NA · completed
- NCT06381336 — A Digital Home-Based Physiotherapy Program for Active Aging · NA · completed
- NCT06498453 — Effectiveness of Telerehabilitation With Trak in Knee and Shoulder Pathology: A Randomized Clinical Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06492551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Trak Health Solutions S.L.
- Last refreshed: 9 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06492551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing